How many institutions held FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in Q4 2023?

152 institutional investors reported FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q: What does CUSIP 31189P102 represent in this 13F holders report?

CUSIP 31189P102 is the security identifier for FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 31189P102

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 122,342,805
Total 13F shares: 95,368,059
Share change: -3,121,583
Total reported value: $356,677,597
Put/Call ratio: 41%
Price per share: $3.74
Number of holders: 152
Value change: -$5,241,221
Number of buys: 59
Number of sells: 95

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 31189P102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	11%	13,124,427	$27,823,785	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	10%	12,484,490	$26,467,121	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	8.9%	10,908,351	$23,125,704	—	30 Sep 2023	13F
Bellevue Group AG	13F	Company	4%	4,851,579	$10,285,347	—	30 Sep 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	3.9%	4,711,664	$9,988,728	—	30 Sep 2023	13F
JOHNSON & JOHNSON	13F	Company	2.8%	3,379,064	$7,163,616	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	2.1%	2,595,174	$5,501,768	—	30 Sep 2023	13F
FEDERATED HERMES, INC.	13F	Company	2%	2,451,544	$5,197,273	—	30 Sep 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2%	2,389,123	$5,064,941	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	1.9%	2,271,925	$4,816,481	—	30 Sep 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.8%	2,149,597	$4,555,000	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	2,064,238	$4,376,185	—	30 Sep 2023	13F
Casdin Capital, LLC	13F	Company	1.7%	2,050,000	$4,346,000	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	2,019,632	$4,281,619	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.6%	1,932,800	$4,097,536	—	30 Sep 2023	13F
Monaco Asset Management SAM	13F	Company	1.5%	1,847,944	$3,917,641	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	1,775,344	$3,764,193	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.3%	1,651,272	$3,500,697	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	1.2%	1,429,416	$3,030,361	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	1%	1,248,212	$2,646,208	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.8%	977,862	$2,074,000	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.72%	886,715	$1,879,836	—	30 Sep 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.59%	724,273	$1,535,459	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.58%	715,149	$1,516,237	—	30 Sep 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.57%	700,000	$1,484,000	—	30 Sep 2023	13F
HRT FINANCIAL LP	13F	Company	0.55%	673,290	$1,427,000	—	30 Sep 2023	13F
Rock Springs Capital Management LP	13F	Company	0.5%	612,215	$1,297,896	—	30 Sep 2023	13F
Boxer Capital, LLC	13F	Company	0.41%	500,000	$1,060,000	—	30 Sep 2023	13F
GCM Grosvenor Holdings, LLC	13F	Company	0.41%	495,916	$1,051,342	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.4%	494,466	$1,048,269	—	30 Sep 2023	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.37%	446,951	$947,536	—	30 Sep 2023	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.36%	444,038	$941,361	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.36%	435,132	$922,480	—	30 Sep 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.35%	426,585	$904,360	—	30 Sep 2023	13F
DARK FOREST CAPITAL MANAGEMENT LP	13F	Company	0.35%	425,901	$902,910	—	30 Sep 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.32%	388,256	$823,103	—	30 Sep 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.31%	380,737	$807,162	—	30 Sep 2023	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.28%	340,554	$721,975	—	30 Sep 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.27%	332,911	$705,771	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.26%	312,788	$663,111	—	30 Sep 2023	13F
FMR LLC	13F	Company	0.25%	307,630	$652,175	—	30 Sep 2023	13F
Yu-Waye Chu	3/4/5	Chief Medical Officer	— class O/S missing	140,676	$614,754	—	18 Apr 2023	3/4/5
Nuveen Asset Management, LLC	13F	Company	0.23%	286,950	$608,334	—	30 Sep 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.23%	275,492	$584,043	—	30 Sep 2023	13F
Squarepoint Ops LLC	13F	Company	0.22%	274,801	$582,578	—	30 Sep 2023	13F
Mark Plavsic	3/4/5	Chief Technical Officer	— class O/S missing	123,705	$540,591	—	10 Jan 2023	3/4/5
GSA CAPITAL PARTNERS LLP	13F	Company	0.21%	253,429	$537,000	—	30 Sep 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.2%	240,575	$510,019	—	30 Sep 2023	13F
Bruce & Co., Inc.	13F	Company	0.16%	200,000	$424,000	—	30 Sep 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.16%	194,911	$413,211	—	30 Sep 2023	13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2023

As of 31 Dec 2023, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,368,059 shares. The largest 10 holders included Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, D. E. Shaw & Co., Inc., Point72 Asset Management, L.P., JOHNSON & JOHNSON, CITADEL ADVISORS LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and ACADIAN ASSET MANAGEMENT LLC. This page lists 153 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

164

Q4 2023 holders

152

Holder diff

-12

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.